Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Sramek

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorderN R Cutler, J M Hesselink, J J Sramek
The Annals of Pharmacotherapy|February 11, 2000
Gender differences in depression and antidepressant pharmacokinetics and adverse eventsE J Frackiewicz, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|November 4, 2000
Review of the acetylcholinesterase inhibitor galanthamineJ J Sramek, E J Frackiewicz, N R Cutler
The Journal of Clinical Psychiatry|April 1, 1983
Effect of lithium on leukocytes: a two-year follow-upE H Pi, J J Sramek, G M Simpson
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1996
The bridging concept: optimizing dose for phase II/III in Alzheimer's diseaseN R Cutler, J J Sramek, J R Kilborn
Drugs|May 1, 1982
Management of tardive dyskinesia: current updateG M Simpson, E H Pi, J J Sramek
The Annals of Pharmacotherapy|October 31, 2000
Mild cognitive impairment: emerging therapeuticsJ J Sramek, A E Veroff, N R Cutler
Drugs|February 1, 1981
Adverse effects of antipsychotic agentsG M Simpson, E H Pi, J J Sramek
Journal of Clinical Psychopharmacology|August 1, 1986
Hepatic reaction to carbamazepineJ F Costa, J J Sramek, J M Herrera
Hospital & Community Psychiatry|April 1, 1986
An update on tardive dyskinesiaG M Simpson, E H Pi, J J Sramek
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorderN R Cutler, J M Hesselink, J J Sramek
The Annals of Pharmacotherapy|February 11, 2000
Gender differences in depression and antidepressant pharmacokinetics and adverse eventsE J Frackiewicz, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|November 4, 2000
Review of the acetylcholinesterase inhibitor galanthamineJ J Sramek, E J Frackiewicz, N R Cutler
The Journal of Clinical Psychiatry|April 1, 1983
Effect of lithium on leukocytes: a two-year follow-upE H Pi, J J Sramek, G M Simpson
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1996
The bridging concept: optimizing dose for phase II/III in Alzheimer's diseaseN R Cutler, J J Sramek, J R Kilborn
Drugs|May 1, 1982
Management of tardive dyskinesia: current updateG M Simpson, E H Pi, J J Sramek
The Annals of Pharmacotherapy|October 31, 2000
Mild cognitive impairment: emerging therapeuticsJ J Sramek, A E Veroff, N R Cutler
Drugs|February 1, 1981
Adverse effects of antipsychotic agentsG M Simpson, E H Pi, J J Sramek
Journal of Clinical Psychopharmacology|August 1, 1986
Hepatic reaction to carbamazepineJ F Costa, J J Sramek, J M Herrera
Hospital & Community Psychiatry|April 1, 1986
An update on tardive dyskinesiaG M Simpson, E H Pi, J J Sramek
Pageof 11